In the largest ever study of the nasal microbiome, researchers have discovered that persistent carriers of Staphylococcus ...
Using BostonGene's multi-parameter immune phenotyping platform and immunotype signature scores, clinicians at MD Anderson profiled peripheral blood from patients with triple-negative breast cancer ...
D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback